跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈(在新的选项卡/窗口中打开)

Elsevier
通过我们出版

World Health Organization (WHO)

Agreement

The World Health Organization (WHO) Policy on Open Access requires funded authors and employees to make their research articles available open access and to be deposited in PubMedCentral (PMC) or Europe PubMed Central (Europe PMC) by the date of publication.

When publishing with Elsevier, WHO employees should choose the Creative Commons Attribution 3.0 Intergovernmental Organization (CC BY 3.0 IGO) end user license. Authors funded by WHO should choose the Creative Commons Attribution (CC BY 4.0) license.

For detailed information about these requirements, please refer to the WHO Open Access policy(在新的选项卡/窗口中打开).

Gold open access

Authors can publish gold open access in any of Elsevier’s fully open access journals(在新的选项卡/窗口中打开) or Transformative Journals(在新的选项卡/窗口中打开). WHO should reimburse reasonable Article Publishing Charge payments for articles published in these titles, in line with its open access policy.

Authors can also publish gold open access in the majority of other Elsevier journals. Where authors wish to publish gold open access in these journals, they will be asked to agree to pay an Article Publishing Charge (APC) at the point of submission. As WHO funds can’t be used to cover these APCs, if authors (or their organizations) are unable to fund these fees they should contact Elsevier to discuss their options.